Non-melanoma skin cancer: new and future synthetic drug treatments.
about
Updates on the Management of Non-Melanoma Skin Cancer (NMSC).Understanding the Molecular Genetics of Basal Cell Carcinoma.Recent advances in systemic targeted therapy for cutaneous T-cell lymphoma.Chimeric Monoclonal Antibody Cetuximab Targeting Epidermal Growth Factor-Receptor in Advanced Non-Melanoma Skin Cancer.
P2860
Non-melanoma skin cancer: new and future synthetic drug treatments.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Non-melanoma skin cancer: new and future synthetic drug treatments.
@en
type
label
Non-melanoma skin cancer: new and future synthetic drug treatments.
@en
prefLabel
Non-melanoma skin cancer: new and future synthetic drug treatments.
@en
P2860
P1476
Non-melanoma skin cancer: new and future synthetic drug treatments
@en
P2093
Teresa Amaral
P2860
P304
P356
10.1080/14656566.2017.1316372
P407
P50
P577
2017-04-17T00:00:00Z